Effect of Some Flavonic Compounds and Ascorbic Acid on Lactoferrin Stimulation of Erythrocyte Glycolysis and Na+/K+-ATPase Activity

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 63, Issue 9-10, 2008, Pages 773-779

  Maneva, Ana ^a   Taleva, Borislava ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Erythrocyte Glycolysis; Lactoferrin; Na+ K+ ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ASCORBIC ACID; FLAVONE DERIVATIVE; LACTIC ACID DERIVATIVE; LACTOFERRIN; QUERCETIN;

ARTICLE; BLOOD; BREAST MILK; DRUG EFFECT; ENZYMOLOGY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; GLYCOLYSIS; HUMAN; METABOLISM;

ASCORBIC ACID; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FLAVONES; GLYCOLYSIS; HUMANS; LACTATES; LACTOFERRIN; MILK, HUMAN; QUERCETIN; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 56249137225     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2008-9-1025     Document Type: Article

References (37)

1. Aisen P. and Brown E. B. (1975), Structure and function of transferrin. Prog. Hematol. 9, 25-56.
2. Bradford M. M. (1976), A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-binding. Anal. Bio-chem. 72, 248-254.
3. Campanella M. E., Chu H., and Low P. S. (2005), Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc. Natl. Acad. Sci. USA 102, 2402-2407.
4. Chaudhary A. and Willett K. L. (2006), Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort. Toxicology 217, 194-205.
5. Cohen M. S., Ekholm J. E., Lustra M. G., and Hanahan D. J. (1976), Biochemical characterization of density-separated human erythrocytes. Biochim. Biophys. Acta 419, 229-237.
6. Dai F., Miao Q., Zhou B., Yang L., and Liu Z. L. (2006), Protective effects of flavonols and their glycosides against free radical-induced oxidative hemolysis of red blood cells. Life Sci. 78, 2488-2493.
7. Davis F. B., Middleton E. Jr., Davis P. J., and Blas S. D. (1983), Inhibition by quercetin of thyroid hormone stimulation in vitro of human red blood cell Ca2+-AT-Pase activity. Cell Calcium 2, 71-81.
8. Fiorani M., De Sanctis R., De Bellis R., and Dacha' M. (2002), Intracellular flavonoids as electron donors for extracellular ferricyanide reduction in human erythrocytes. Free Radic. Biol. Med. 32, 64-72.
9. Gao G., Sofic E., and Prior R. L. (1997), Antioxidant and prooxidant behavior of flavonoids: structure-activity. Free Radic. Biol. Med. 22, 749-760.
10. Hirano T., Oka K., and Akiba M. (1989), Effects of synthetic and natural flavonoids on Na+/K+-ATPase: Aspects of the structure-activity relationship and action mechanism. Life Sci. 45, 1111-1117.
11. Kimer P. A. and Westhead E. W. (1979), Phosphorylation and inhibition of human erythrocyte pyruvate kinase by erythrocyte membrane. Biochem. Biophys. Res. Commun. 91, 50-55.
12. Kuronuma K., Sano H., Kato K., Kudo K., Hyakushima N., Yokota S., Takahashi H., Fujii N., Suzuki H., Kodama T., Abe S., and Kuroki Y. (2004), Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A. J. Biol. Chem. 279, 21421-21430.
13. Landolfi R., Mower R. L., and Steiner M. (1984), Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem. Pharmacol. 33, 1525-1530.
14. Levay P. F. and Viljoen M. (1995), Lactoferrin: a general review. Haematologica 80, 252-267.
15. Maccaglia A., Mallozzi C., and Minetti M. (2003), Differential effects of quercetin and resveratrol on Band 3 tyrosine phosphorylation signalling of red blood cells. Biochem. Biophys. Res. Commun. 305, 541-547.
16. Mackawa T., Fujihara M., and Ohtsuki K. (2002), Characterization of human lactoferricin as a potent protein kinase CK2 activator regulated by A-kinase in vitro. Biol. Pharm. Bull. 25, 118-121.
17. Madshus I. H. (1988), Regulation of intercellular pH in eukaryotic cells. Biochem. J. 250, 1-8.
18. Manach C., Williamson G., Morand C., Scalbert A., and Rémésy C. (2005), Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81, 230S-242S.
19. Maneva A., Taleva B., and Maneva L. (2003), Lactofer-rin-protector against oxidative stress and regulator of glycolysis in human erythrocytes. Z. Naturforsch. 58c, 256-262.
20. Maneva A., Angelova-Gateva P., Taleva B., Maneva-Radicheva L., and Manev V. (2007), Lactoferrin stimulates erythrocyte Na+/K+-adenosine triphosphatase: Effect of some modulators of membrane phosphorylation. Z. Naturforsch. 62c, 897-904.
21. Maridonneau-Parini I., Braquet P., and Garay R. P. (1986), Heterogeneous effect of flavonoids on K+ loss and lipid peroxidation induced by oxygen free radicals in human red blood cells. Pharmacol. Res. Commun. 1, 61-72.
22. Matter W. F., Brown R. F., and Vlahos C. J. (1992), The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem. Biophys. Res. Commun. 186, 624-631.
23. May J. M. and Qu Z. C. (1999), Ascorbate-dependent electron transfer across the human erythrocyte membrane. Biochim. Biophys. Acta 1421, 19-31.
24. May J. M., Qu Z. C., and Cobb C. E. (2004), Human erythrocyte recycling of ascorbic acid: relative contributions from the ascorbate free radical and dehydro-ascorbic acid. J. Biol. Chem. 279, 14975-14982.
25. Middleton E., Kandaswami C., and Theoharides T. C. (2000), The effect of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer. Pharmacol. Rev. 52, 673-751.
26. Minetti G. and Low P. S. (1997), Erythrocyte signal transduction pathways and their possible functions. Curr. Opin. Hematol. 4, 116-121.
27. Orringer E. P. and Roer M. E. S. (1979), An ascorbic acid mediated erythrocyte transmembrane reducing system in human erythrocytes. J. Clin. Invest. 63, 53-58.
28. Sartoli M., Ceolotto G., and Semplicini A. (1999), MAP-Kinase and regulation of the sodium-proton exchanger in human red blood cell. Biochim. Biophys. Acta 1421, 140-148.
29. Schipfer W., Neophytou B., Trobisch R., Groiss O., and Goldenberg H. (1985), Reduction of extracellular potassium ferricyanide by transmembrane NADH: (acceptor) oxidoreductase of human erythrocytes. Int. J. Biochem. 17, 819-823.
30. Seow C. J., Chue S. C., and Wong W. S. (2002), Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways in vitro. Eur. J. Pharmacol. 443, 189-196.
31. Sun I. L., Crane F. L., Morre D. J., Low H., and Faulk W. P. (1991), Lactoferrin activates plasma membrane oxidase and Na+/H+ antiport activity. Biochem. Bio-phys. Res. Commun. 176, 498-504.
32. Taleva B., Maneva A., and Sirakov L. (1999), Essential metal ions alter the lactoferrin binding to the erythrocyte plasma membrane receptors. Biol. Trace Elem. Res. 68, 13-24.
33. Uhie S., Medalia O., Waldron R., Dumdey R., Henklein P., Bech-Otschir D., Huang X., Berse M., Sperling J., Schade R., and Dubiel W. (2003), Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J. 22, 1302-1312.
34. Vésérhelyi B., Szabó T., Vér Á., and Tulassay T. (1997), Measurement of Na+/K+-ATPase activity with anautomated analyzer. Clin. Chem. 43, 1986-1987.
35. Williams R. J., Spencer J. P., and Rice-Evans C. (2004), Flavonoids: antioxidants or signaling molecules? Free Radical Biol. Med. 36, 838-849.
36. Xia P., Kramer M., and King G. L. (1995), Identification of the mechanism for the inhibition of Na+/K+-adeno-sine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholi-pase A2. J. Clin. Invest. 96, 733-740.
37. Zhang X. M., Huang S. P., and Xu Q. (2004), Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway. Cancer Chemother. Pharmacol. 53, 82-88.